Your browser doesn't support javascript.
Do proton pump inhibitors influence SARS-CoV-2 related outcomes? A meta-analysis.
Li, Guo-Fu; An, Xiao-Xiao; Yu, Yichao; Jiao, Li-Rong; Canarutto, Daniele; Yu, Guo; Wang, Guangji; Wu, Dan-Na; Xiao, Yin.
  • Li GF; Clinical Medical College, Yangzhou University, Yangzhou, China.
  • An XX; Institution of Drug Clinical Trial, Subei People's Hospital, Yangzhou, China.
  • Yu Y; Institution of Drug Clinical Trial, Subei People's Hospital, Yangzhou, China.
  • Jiao LR; College of Pharmacy, Dalian Medical University, Dalian, Liaoning, China.
  • Canarutto D; Department of Pharmaceutics, University of Florida, Gainesville, Florida, USA.
  • Yu G; Institution of Drug Clinical Trial, Subei People's Hospital, Yangzhou, China.
  • Wang G; College of Pharmacy, Dalian Medical University, Dalian, Liaoning, China.
  • Wu DN; Faculty of Medicine and Surgery, Vita Salute San Raffaele University, Milan, Italy.
  • Xiao Y; Clinical Medical College, Yangzhou University, Yangzhou, China guoyu@yzu.edu.cn.
Gut ; 70(9): 1806-1808, 2021 09.
Article in English | MEDLINE | ID: covidwho-919103

Full text: Available Collection: International databases Database: MEDLINE Main subject: Gastroesophageal Reflux / COVID-19 Type of study: Reviews Limits: Humans Language: English Journal: Gut Year: 2021 Document Type: Article Affiliation country: Gutjnl-2020-323366

Full text: Available Collection: International databases Database: MEDLINE Main subject: Gastroesophageal Reflux / COVID-19 Type of study: Reviews Limits: Humans Language: English Journal: Gut Year: 2021 Document Type: Article Affiliation country: Gutjnl-2020-323366